Overview

A Clinical Study Assessing the Potential of Piboserod for the Treatment of Heart Failure

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether piboserod, a serotonin-4 receptor antagonist, is effective for the treatment of patients with congestive heart failure.
Phase:
Phase 2
Details
Lead Sponsor:
Bio-Medisinsk Innovasjon
Collaborator:
Smerud Medical Research International AS